Company Data
Moleculin Biotech Inc.
Ticker
MBRX
Current Price
$0.87 -4.16%
Market Cap
$12.3M
Price Target
Refer to Report
Volume
106.3K
52wk Range
$0.3975 - $4.9
Overview
Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis.